van Wijngaarden I, Tulp M T, Soudijn W
Department of Medicinal Chemistry, Duphar B.V., Weesp, The Netherlands.
Eur J Pharmacol. 1990 Jun 12;188(6):301-12. doi: 10.1016/0922-4106(90)90190-9.
Since the demonstration that serotonin (5-hydroxytryptamine, 5-HT) interacts with different (sub)types of membrane receptors, several compounds have been proposed as potent and selective ligands for one of these 5-HT subtypes. Unfortunately, specific and highly selective ligands (selectivity ratios greater than or equal to 1000) for the majority of 5-HT subtypes are still lacking. A few compounds are selective (ratios greater than or equal to 100), but most of the reputed 'selective' tools display affinities for other 5-HT subtypes and/or other (neuro-) transmitter receptors. Mainly due to different interpretations of the concept of selectivity, many of these nonselective compounds are still used to characterize 5-HT receptors. In this paper, we present the affinities (obtained by radioligand binding studies) of the most selective tools known today for each of the 5-HT subtypes and discuss the structure-activity relationships of some interesting series. The potential use of several of these selective ligands as pharmacological tools and therapeutics will be briefly reviewed.
自从证明血清素(5-羟色胺,5-HT)能与不同类型的膜受体相互作用以来,已经提出了几种化合物作为这些5-HT亚型之一的强效和选择性配体。不幸的是,大多数5-HT亚型仍然缺乏特异性和高选择性的配体(选择性比率大于或等于1000)。一些化合物具有选择性(比率大于或等于100),但大多数所谓的“选择性”工具对其他5-HT亚型和/或其他(神经)递质受体也有亲和力。主要由于对选择性概念的不同解释,许多这些非选择性化合物仍被用于表征5-HT受体。在本文中,我们展示了当今已知的最具选择性的工具对每种5-HT亚型的亲和力(通过放射性配体结合研究获得),并讨论了一些有趣系列的构效关系。还将简要回顾其中几种选择性配体作为药理学工具和治疗药物的潜在用途。